RoSA Colorectal Cancer Diagnostics Market to 2032
Overview
The RoSA Colorectal Cancer Diagnostics Market is expected to reach a 49.82 USD Million by 2032 and is projected to grow at a CAGR of 8.66% from 2025 to 2032.
Revenue, 2024 (USD Million)
31.22
Forecast, 2032 (USD Million)
49.82
CAGR, 2024 - 2032
8.66%
Report Coverage
RoSA
RoSA Colorectal Cancer Diagnostics Market 2018-2032 USD Million
RoSA Colorectal Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 31.22 USD Million
- Projected Market Size (2032): 49.82 USD Million
- CAGR (2025-2032): 8.66%
Key Findings of RoSA Colorectal Cancer Diagnostics Market
- The RoSA Colorectal Cancer Diagnostics Market was valued at 31.22 USD Million in 2024.
- The RoSA Colorectal Cancer Diagnostics Market is likely to grow at a CAGR of 8.66% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Instruments in Product Type Segment accounted for the largest share of the market with a revenue of 22.66 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 11.42% during the forecast period from 2024 to 2032.
RoSA Colorectal Cancer Diagnostics Market Scope
RoSA Colorectal Cancer Diagnostics Market Segmentation & Scope
Product Type
- Consumables & Accessories
- Instruments
Test Type
- Others
- Biopsy
- Tumor Markers
- Imaging Test
- Blood Test
- Stool Examination
Cancer Stages
- Stage 0
- Stage I
- Stage II
- Stage IV
- Stage III
Cancer Type
- Others
- Carcinoid Tumors
- Gastrointestinal Stromal Tumors
- Colorectal Lymphoma
- Adenocarcinoma
Age Group
- Pediatric
- Adults
- Geriatric
End User
- Others
- Academic Institutes
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
RoSA Colorectal Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 31.22 USD Million |
| Market Value in 2032 | 49.82 USD Million |
| CAGR (2025-2032) | 8.66% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,Test Type,Cancer Stages,Cancer Type,Age Group,End User |
Regional Insights:
-
Leading Market (2024-2032): RoSA, leading in terms of revenue 31.22 USD Million in 2024
- Key Country: RoSA, leading in terms of revenue with value of 31.22 USD Million in 2024.
Segments and Scope
-
RoSA Colorectal Cancer Diagnostics Market to 2032, By Product Type
- Instruments is the largest segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a revenue of 22.66 USD Million in the year 2024.
- Instruments is the Fastest growing segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 9.41 % in forecast period 2025-2032.
-
RoSA Colorectal Cancer Diagnostics Market to 2032, By Test Type
- Stool Examination is the largest segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a revenue of 14.22 USD Million in the year 2024.
- Stool Examination is the Fastest growing segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 10.48 % in forecast period 2025-2032.
-
RoSA Colorectal Cancer Diagnostics Market to 2032, By Cancer Stages
- Stage III is the largest segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a revenue of 14.64 USD Million in the year 2024.
- Stage III is the Fastest growing segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 10.32 % in forecast period 2025-2032.
-
RoSA Colorectal Cancer Diagnostics Market to 2032, By Cancer Type
- Adenocarcinoma is the largest segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a revenue of 20.31 USD Million in the year 2024.
- Adenocarcinoma is the Fastest growing segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 9.35 % in forecast period 2025-2032.
-
RoSA Colorectal Cancer Diagnostics Market to 2032, By Age Group
- Geriatric is the largest segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a revenue of 16.13 USD Million in the year 2024.
- Geriatric is the Fastest growing segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 9.10 % in forecast period 2025-2032.
-
RoSA Colorectal Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a revenue of 11.20 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in RoSA Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 11.42 % in forecast period 2025-2032.
RoSA Colorectal Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Illumina, Inc. | |||
| Koninklijke Philips N.V. | |||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Bio-Rad Laboratories, Inc. | |||
RoSA Colorectal Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
RoSA Colorectal Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoSA Colorectal Cancer Diagnostics Market is segmented based on Segmentation Product Type,Test Type,Cancer Stages,Cancer Type,Age Group,End User.
RoSA Colorectal Cancer Diagnostics Market was valued at USD 31.22(Revenue in USD Million) in 2021.
RoSA Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 8.66% during the forecast period of 2024 to 2032.
The Instruments segment is expected to dominate the RoSA Colorectal Cancer Diagnostics Market, holding a largest market share of 22.66 USD Million in 2024
RoSA Colorectal Cancer Diagnostics Market Scope
RoSA Colorectal Cancer Diagnostics Market Segmentation & Scope
Product Type
- Consumables & Accessories
- Instruments
Test Type
- Others
- Biopsy
- Tumor Markers
- Imaging Test
- Blood Test
- Stool Examination
Cancer Stages
- Stage 0
- Stage I
- Stage II
- Stage IV
- Stage III
Cancer Type
- Others
- Carcinoid Tumors
- Gastrointestinal Stromal Tumors
- Colorectal Lymphoma
- Adenocarcinoma
Age Group
- Pediatric
- Adults
- Geriatric
End User
- Others
- Academic Institutes
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
Frequently Asked Questions
The RoSA Colorectal Cancer Diagnostics Market is segmented based on Segmentation Product Type,Test Type,Cancer Stages,Cancer Type,Age Group,End User.
RoSA Colorectal Cancer Diagnostics Market was valued at USD 31.22(Revenue in USD Million) in 2021.
RoSA Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 8.66% during the forecast period of 2024 to 2032.
The estimated market value of the RoSA Colorectal Cancer Diagnostics Market for final year is USD 49.82 (USD Million).
RoSA Colorectal Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The RoSA Colorectal Cancer Diagnostics Market is segmented based on Segmentation Product Type,Test Type,Cancer Stages,Cancer Type,Age Group,End User.
RoSA Colorectal Cancer Diagnostics Market was valued at USD 31.22(Revenue in USD Million) in 2021.
RoSA Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 8.66% during the forecast period of 2024 to 2032.
The estimated market value of the RoSA Colorectal Cancer Diagnostics Market for final year is USD 49.82 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.